skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In vitro effects of the anti-Alzheimer drug memantine on the human erythrocyte membrane and molecular models

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1];  [2]; ;  [3]
  1. Faculty of Chemical Sciences, University of Concepción, Concepción (Chile)
  2. Faculty of Biological Sciences, University of Concepción, Concepción (Chile)
  3. Malopolska Centre of Biotechnology, Jagiellonian University, Kraków (Poland)

Memantine is a NMDA antagonist receptor clinically used for treating Alzheimer's disease. NMDA receptors are present in the human neurons and erythrocyte membranes. The aim of the present study was to investigate the effects of memantine on human erythrocytes. With this purpose, the drug was developed to in vitro interact with human red cells and bilayers built-up of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE). The latter represent lipids respectively present in both outer and inner monolayers of the red cell membrane. Results obtained by scanning electron microscopy (SEM) showed that memantine changed the normal biconcave shape of red cells to cup-shaped stomatocytes. According to the bilayer-couple hypothesis the drug intercalated into the inner monolayer of the erythrocyte membrane. Experimental results obtained by X-ray diffraction on multibilayers of DMPC and DMPE, and by differential scanning calorimetry on multilamellar vesicles indicated that memantine preferentially interacted with DMPC in a concentration-dependent manner. Thus, it can be concluded that in the low therapeutic plasma concentration of circa 1 μM memantine is located in NMDA receptor channel without affecting the erythrocyte shape. However, at higher concentrations, once the receptors became saturated excess of memantine molecules (20 μM) would interact with phosphoinositide lipids present in the inner monolayer of the erythrocyte membrane inducing the formation of stomatocytes. However, 40–50 μM memantine was required to interact with isolated phosphatidylcholine bilayers. - Highlights: • The interaction of memantine with human erythrocytes and lipid bilayers were assessed. • Memantine induced morphological changes to human erythrocytes. • Memantine interacted with classes of phospholipids present in the erythrocyte membrane. • Results support the hypothesis that memantine interacts with NMDA receptors.

OSTI ID:
22696837
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 483, Issue 1; Other Information: Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes
Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:22696837

Effects of phenylpropanolamine (PPA) on in vitro human erythrocyte membranes and molecular models
Journal Article · Fri Mar 18 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:22696837

Human erythrocytes and neuroblastoma cells are affected in vitro by Au(III) ions
Journal Article · Fri Jun 25 00:00:00 EDT 2010 · Biochemical and Biophysical Research Communications · OSTI ID:22696837